4D Molecular Therapeutics, Inc. (FDMT)
4D Molecular Therapeutics, Inc. (FDMT) has a 21-report earnings history dating back to May 13, 2021. Its average absolute post-earnings move is ±4.25%, and 61.9% of those reactions were positive. Its largest post-earnings gain was +12.75% (Nov 09, 2022) and its largest decline was -8.61% (Feb 28, 2025). The next earnings report is predicted for 2026-08-10 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±4.25%
Positive %
61.9%
Negative %
38.1%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 07, 2026 | ☽ POST | $10.29 | $10.29 | $9.96 | 37,032 | +1.86% | open_in_new |
| Mar 18, 2026 | ☽ POST | $8.52 | $8.60 | $8.56 | 534,700 | +4.91% | open_in_new |
| Nov 10, 2025 | ☀ PRE | $10.35 | $10.63 | $10.17 | 1,297,000 | -3.14% | open_in_new |
| Aug 11, 2025 | ☀ PRE | $5.62 | $5.82 | $5.53 | 579,300 | -1.78% | open_in_new |
| May 08, 2025 | ☽ POST | $3.12 | $3.32 | $3.24 | 393,300 | -4.94% | open_in_new |
| Feb 28, 2025 | ☽ POST | $4.45 | $4.64 | $4.53 | 1,233,200 | -8.61% | open_in_new |
| Nov 13, 2024 | ☽ POST | $7.98 | $8.02 | $7.71 | 534,500 | +4.02% | open_in_new |
| Aug 08, 2024 | ☽ POST | $15.00 | $15.00 | $14.73 | 502,500 | +0.48% | open_in_new |
| May 09, 2024 | ☽ POST | $26.41 | $26.84 | $25.64 | 323,000 | +0.23% | open_in_new |
| Feb 29, 2024 | ☽ POST | $28.65 | $29.13 | $28.02 | 477,100 | +4.82% | open_in_new |
| Nov 09, 2023 | ☽ POST | $10.83 | $10.83 | $10.50 | 286,000 | +5.24% | open_in_new |
| Aug 09, 2023 | ☽ POST | $16.82 | $17.11 | $17.04 | 224,700 | -2.29% | open_in_new |
| May 11, 2023 | ☽ POST | $17.79 | $18.24 | $16.90 | 808,800 | +5.98% | open_in_new |
| Mar 15, 2023 | ☽ POST | $18.03 | $18.43 | $17.37 | 351,200 | +5.7% | open_in_new |
| Nov 09, 2022 | ☽ POST | $8.38 | $8.80 | $8.63 | 208,300 | +12.75% | open_in_new |
| Aug 11, 2022 | ☽ POST | $10.62 | $11.06 | $10.40 | 157,900 | -8.27% | open_in_new |
| May 12, 2022 | ☽ POST | $9.21 | $9.95 | $9.42 | 270,500 | -4.35% | open_in_new |
| Mar 28, 2022 | ☽ POST | $15.15 | $15.73 | $15.41 | 114,900 | +6.1% | open_in_new |
| Nov 10, 2021 | ☽ POST | $24.95 | $25.25 | $24.72 | 132,600 | +0.2% | open_in_new |
| Aug 12, 2021 | ☽ POST | $27.80 | $28.72 | $27.90 | 114,200 | -3.19% | open_in_new |
| May 13, 2021 | ☽ POST | $27.99 | $28.13 | $26.42 | 134,600 | +0.3% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±4.25%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260602 | open_in_new SEC.gov |
| 144 | 20260601 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| EFFECT | 20260513 | open_in_new SEC.gov |
| 10-Q | 20260507 | open_in_new SEC.gov |
| 8-K | 20260507 | open_in_new SEC.gov |
| S-3 | 20260507 | open_in_new SEC.gov |
| ARS | 20260428 | open_in_new SEC.gov |
| DEFA14A | 20260428 | open_in_new SEC.gov |
Frequently asked about FDMT earnings
When does 4D Molecular Therapeutics, Inc. report earnings next? expand_more
4D Molecular Therapeutics, Inc. (FDMT)'s next earnings date is approximate for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does FDMT stock move after earnings? expand_more
Over 21 reports, FDMT has moved an average of ±4.25% the session after earnings, closing higher 61.9% of the time.
What was FDMT's biggest post-earnings move? expand_more
FDMT's largest post-earnings gain on record was +12.75% on Nov 09, 2022, and its largest decline was -8.61% on Feb 28, 2025.
Where can I find 4D Molecular Therapeutics, Inc.'s SEC filings? expand_more
All of 4D Molecular Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right